In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 23 | Yes |
Popular Name: N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea N'-(Pyrrolidino[2,1-B]Isoindolin…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.81 | -3.42 | -20.42 | 2 | 6 | 0 | 74 | 308.341 | 2 | ↓ |
Lo Low (pH 4.5-6) | 1.81 | -3.78 | -44.19 | 3 | 6 | 1 | 75 | 309.349 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.01e-01 g/l | DrugBank-experimental |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 78 | 0.43 | Binding ≤ 10μM |
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 78 | 0.43 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 120 | 0.42 | Binding ≤ 10μM |
CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 120 | 0.42 | Binding ≤ 10μM |
CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 120 | 0.42 | Binding ≤ 10μM |
CCND1-1-E | G1/S-specific Cyclin D1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.44 | Binding ≤ 10μM |
CCND2-1-E | G1/S-specific Cyclin D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 42 | 0.45 | Binding ≤ 10μM |
CDK1-3-E | Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 1800 | 0.35 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 80 | 0.43 | Binding ≤ 10μM |
CDK4-2-E | Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 42 | 0.45 | Binding ≤ 10μM |
CDK6-1-E | Cyclin-dependent Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.44 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6700 | 0.31 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 2300 | 0.34 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.32 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.34 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 78 | 0.43 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 78 | 0.43 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 120 | 0.42 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 440 | 0.39 | Binding ≤ 1μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 2 | 0.53 | Binding ≤ 1μM |
CDK6_HUMAN | Q00534 | Cyclin-dependent Kinase 6, Human | 71 | 0.44 | Binding ≤ 1μM |
CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 71 | 0.44 | Binding ≤ 1μM |
CCND2_HUMAN | P30279 | G1/S-specific Cyclin D2, Human | 42 | 0.45 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 120 | 0.42 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 120 | 0.42 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 120 | 0.42 | Binding ≤ 1μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 78 | 0.43 | Binding ≤ 10μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 78 | 0.43 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 120 | 0.42 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 440 | 0.39 | Binding ≤ 10μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 2 | 0.53 | Binding ≤ 10μM |
CDK6_HUMAN | Q00534 | Cyclin-dependent Kinase 6, Human | 71 | 0.44 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 6700 | 0.31 | Binding ≤ 10μM |
CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 71 | 0.44 | Binding ≤ 10μM |
CCND2_HUMAN | P30279 | G1/S-specific Cyclin D2, Human | 42 | 0.45 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 120 | 0.42 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 120 | 0.42 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 120 | 0.42 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 5000 | 0.32 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 2300 | 0.34 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 2800 | 0.34 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of the pre-replicative complex | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DAP12 signaling | |
Depolymerisation of the Nuclear Lamina | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream signal transduction | |
Downstream TCR signaling | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
ERK1 activation | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
Generation of second messenger molecules | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GPVI-mediated activation cascade | |
Interleukin-2 signaling | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Neurophilin interactions with VEGF and VEGFR | |
Nuclear Pore Complex (NPC) Disassembly | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PIP3 activates AKT signaling | |
Polo-like kinase mediated events | |
Pre-NOTCH Transcription and Translation | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
RMTs methylate histone arginines | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signaling by activated point mutants of FGFR1 | |
Signaling by FGFR mutants | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
Transcriptional regulation of white adipocyte differentiation | |
Translocation of ZAP-70 to Immunological synapse | |
Ubiquitin-dependent degradation of Cyclin D1 | |
VEGF binds to VEGFR leading to receptor dimerization |
No pre-computed analogs available. Try a structural similarity search.